Synthesis and antiproliferative activity of pyrrolo[3,2-b]pyridine derivatives against melanoma

  • Bioorg Med Chem Lett. 2010 Jan 1;20(1):413-7. doi: 10.1016/j.bmcl.2009.08.005.
Hee Jin Kim  1 ,  Myung-Ho Jung ,  Hwan Kim ,  Mohammed I El-Gamal ,  Tae Bo Sim ,  So Ha Lee ,  Jun Hee Hong ,  Jung-Mi Hah ,  Jung-Hyuck Cho ,  Jung Hoon Choi ,  Kyung Ho Yoo ,  Chang-Hyun Oh
Affiliations
  • 1. Biomaterials Research Center, Korea Institute of Science and Technology, PO Box 131, Cheongryang, Seoul 130-650, Republic of Korea.
PMID: 19897366 DOI: 10.1016/j.bmcl.2009.08.005
Abstract

Synthesis of a new series of diarylureas and amides having pyrrolo[3,2-b]pyridine scaffold is described. Their in vitro antiproliferative activity against human melanoma cell line A375 and HS 27 human fibroblast cell line was tested and the effect of substituents on the pyrrolo[3,2-b]pyridine was investigated. The newly synthesized compounds, except meta-substituted derivatives (Ij-k and Iv-w), generally showed superior or similar activity against A375 to Sorafenib. Among all of these derivatives, compounds Ir and It having 5-benzylamide substituted 4'-amide moieties showed the most potent antiproliferative activity against A375.